Senior insider sale
Chief Financial Officer at SPYRE THERAPEUTICS, INC. — senior position signals high conviction
$5.23M
58.23K shares
What this filing means
BURROWS SCOTT L plans to sell 58.23K shares of SPYRE THERAPEUTICS, INC. valued at approximately $5.23M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/30/2026ACC: 0001950047-26-009876
Officer· Chief Financial Officer
Since Mar 2026
58.23K
Shares to sell
$5.23M
Approx. market value
17.50K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
9/30/2026
17.50KTotal acquired17.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/30/2026 | Stock Option Exercise Cash | 17.50K | — |
| Total | 17.50K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
18.23K
Market value
$1.63M
9/2/2026
—Completed
Units to sell
7.50K
Market value
$654.8K
9/1/2026
—Completed
Units to sell
7.50K
Market value
$716.8K
8/3/2026
—Completed
Units to sell
7.50K
Market value
$658.0K
7/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
17.50K
Market value
$1.57M
9/30/2026
Total
Units
58.23K
Value
$5.23M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/2/2026 | 18.23K | $1.63M | — | Completed |
9/1/2026 | 7.50K | $654.8K | — | Completed |
8/3/2026 | 7.50K | $716.8K | — | Completed |
7/1/2026 | 7.50K | $658.0K | — | Completed |
| Planned — Approximate Date | ||||
9/30/2026 | 17.50K | $1.57M | NASDAQ | Planned |
| Total | 58.23K | $5.23M | ||